Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Dr. Peter AIDS Foundation has announced a partnership with B Sharp Technologies Inc., of Toronto, to implement a web-based client admission, discharge and transfer solution that will manage clients in both of the organization’s 24-hour residential care and day-health programs.

Related Articles

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09    Relevance Score: 89%

Prostate cancer: Quality of life after radiation and androgen deprivation
NCP Urology, 10/13/09    Relevance Score: 87%

Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09    Relevance Score: 80%

Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
Journal of General Internal Medicine, 10/26/09    Relevance Score: 77%

Today in M&A/Partnerships...keeping you current

Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address